Issue Date: September 3, 2012
Hospira Will Acquire Indian API Facility
The injectable drug maker Hospira has agreed to acquire an active pharmaceutical ingredient manufacturing facility and related R&D operation from India’s Orchid Chemicals & Pharmaceuticals. Hospira says buying the FDA-inspected plant, for about $200 million, will reduce its costs and support continued supply of key antibiotics. The plant, in Aurangabad, employs some 640 chemists, engineers, and technicians. The R&D facility, in Chennai, employs 160 scientific personnel. Hospira acquired Orchid’s generic injectable drug business in 2010.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society